home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

355 rows where filing_period = "second_quarter", filing_year = 2022 and issue_code = "MED" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, is_termination, received_date (date)

issue_code 1

  • MED · 355 ✖

filing_year 1

  • 2022 · 355 ✖

filing_period 1

  • second_quarter · 355 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
2813274 MS. TAMI WAHL 181d52c4-6e41-4a76-b56b-7978f5593411 2T MS. TAMI WAHL 401104405 ASSOCIATION OF CANNABIS SPECIALISTS 2022 second_quarter MED Ensuring a medical cannabis paradigm is included in any comprehensive federal reform legislation and that such paradigm is subject to appropriate standards to allow best possible patient outcomes. HOUSE OF REPRESENTATIVES,SENATE     0 1 2022-06-09T11:18:37-04:00
2813819 FRANCIS EDWARD & CRONIN, INC. d32eaa18-695d-431e-82a6-fbf33fdf0bfb Q2 FRANCIS EDWARD & CRONIN, INC. 311314 CURE ALZHEIMER'S FUND 2022 second_quarter MED Issues and legislation related to Alzheimer's disease research Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE 20000   0 0 2022-07-01T00:16:06-04:00
2813820 FRANCIS EDWARD & CRONIN, INC. 04a8d6d7-64c0-407a-a10e-2baf92c43d1a Q2 FRANCIS EDWARD & CRONIN, INC. 311314 PATH DECISION SUPPORT SOFTWARE, LLC 2022 second_quarter MED Issues and legislation related to diabetes treatment and diagnosis HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),SENATE,Veterans Affairs, Dept of (VA)     0 0 2022-07-01T00:20:15-04:00
2813878 MARSHALL BRACHMAN 1adf0cca-79bf-4f29-a066-68ac9c48e2ab Q2 MARSHALL BRACHMAN 6848 BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM 2022 second_quarter MED support funding for medical research programs HOUSE OF REPRESENTATIVES,SENATE 33000   0 0 2022-07-01T10:05:48-04:00
2813996 KNIGHT CAPITOL CONSULTANTS f2124a74-56f4-463d-a62d-fe13605202bf 2T KNIGHT CAPITOL CONSULTANTS 40036301 PERSPECTUM 2022 second_quarter MED Food and Drug Administration regulation of medical devices, monitor development of Medical device user fee legislation Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 40000   0 1 2022-07-01T14:08:42-04:00
2814068 AUBURN HEALTH STRATEGIES, LLC 751e0440-4ead-4f1f-a688-086890f0d117 Q2 AUBURN HEALTH STRATEGIES, LLC 292697 AMERICAN PROFICIENCY INSTITUTE 2022 second_quarter MED Proficiency testing for clinical laboratories Health & Human Services, Dept of (HHS),Office of Management & Budget (OMB)     0 0 2022-07-01T18:08:07-04:00
2814332 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 503b1464-6b58-48a4-9430-9b9e8650d321 Q2 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 400361684 PPLA 2022 second_quarter MED Pharmaceutical Labeling Food & Drug Administration (FDA) 18700   0 0 2022-07-05T10:58:00-04:00
2814431 NATURAL RESOURCE RESULTS LLC a64d7f79-f08d-42e7-a55a-7c8da4819729 Q2 NATURAL RESOURCE RESULTS LLC 321555 SHINE MEDICAL TECHNOLOGIES 2022 second_quarter MED Support funding at DOE for fusion technology development. Energy, Dept of,SENATE 30000   0 0 2022-07-05T13:31:54-04:00
2814651 AMERICAN COLLEGE OF CLINICAL PHARMACY b1599788-aa86-4966-8b2b-21786f53e3fb Q2 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2022 second_quarter MED Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   144981 0 0 2022-07-06T05:17:58-04:00
2814702 WAYNE STATE UNIVERSITY, DETROIT, MICHIGAN 3b2b1900-f5c7-43b6-993f-be10d969d29a Q2 WAYNE STATE UNIVERSITY, DETROIT, MICHIGAN 48805 WAYNE STATE UNIVERSITY, DETROIT, MICHIGAN 2022 second_quarter MED No agencies lobbied in this issue area. HOUSE OF REPRESENTATIVES,SENATE     0 0 2022-07-06T10:42:45-04:00
2814795 UNIVERSITY OF KENTUCKY 4f161aad-4de4-47cf-bbb8-ed4ea3691aba Q2 UNIVERSITY OF KENTUCKY 400287372 UNIVERSITY OF KENTUCKY 2022 second_quarter MED H.R.5585 - ARPA-H Act NIH Funding - FY23 Appropriations Act HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   80850 0 0 2022-07-06T11:55:37-04:00
2815309 FEDERAL SOLUTIONS, LLC 0e1df86e-0466-4f48-99e9-5862a65b63b6 Q2 FEDERAL SOLUTIONS, LLC 311371 MISSISSIPPI STATE UNIVERSITY 2022 second_quarter MED Labor/HHS/Education Appropriations: Provisions relating to disease research HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2022-07-07T16:27:01-04:00
2815572 COVINGTON & BURLING LLP 60f2949c-4423-463d-a5b4-576c74dc43c9 Q2 COVINGTON & BURLING LLP 11195 SL 2T, LLC ("SMARTLABS") 2022 second_quarter MED Education and support for policies and funding to advance turnkey, co-located, on-demand pharma grade research laboratory environments, including relating to the PREVENT Pandemics Act (S. 3799) and the ARPA-H Act (H.R. 5585). HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2022-07-08T11:29:36-04:00
2815578 HELIX, INC. 32b77abb-1f9f-4ff7-8556-3c2d77792d22 Q2 HELIX, INC. 401106164 HELIX, INC. 2022 second_quarter MED genomic research and testing, COVID-19 testing and research, Lab Developed Tests Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE,White House Office   36520 0 0 2022-07-08T11:32:54-04:00
2815617 CHAMBER HILL STRATEGIES bc421a8d-326f-4763-adbc-dc9d08937d71 Q2 CHAMBER HILL STRATEGIES 400645947 SANFORD HEALTH 2022 second_quarter MED H.R. 6000, Cures 2.0 Act. HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2022-07-08T12:09:43-04:00
2815871 POWERS PYLES SUTTER & VERVILLE, P.C. d3dc45d4-88fa-465b-a25a-b73585c0745e Q2 POWERS PYLES SUTTER & VERVILLE, P.C. 32008 MOSES WEITZMAN HEALTH SYSTEM, INC. 2022 second_quarter MED Consolidated Appropriations Act, FY 2022, H.R. 2471, now P.L. 117-103 American Rescue Plan Act of 2021, H.R. 1319 now P.L. 117-2 Infrastructure Investment and Jobs Act, H.R. 3684, P.L. 117-58 Build Back Better Act, H.R. 5376 FY 2023 House, Senate Department of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2023 House, Senate Department of Agriculture Appropriations Bills FY 2023 House, Senate Commerce, Justice, Science Appropriations Bills FY 2023 House, Senate Financial Services and General Government Appropriations Bills FY 2023 House, Senate Department of Homeland Security Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Legislation to Reauthorize and Fund Postgraduate Nurse Practitioner Residency and Fellowship Programs, Postgraduate Psychiatric Fellowships, Medical Assistant Training Programs and other Health Workforce Programs House, Senate Comprehensive Addiction and Recovery Legislation House, Senate Legislation to Reform Behavioral Health and Substance Use Disorder Prevention and Treatment House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Legislation to Train More Primary Care and Other Providers House Legislation to Implement Electronic Provider Consultations (E-Consults) with Related Telemedicine in Health Centers and Rural Health Clinics House, Senate Infrastructure Bills Administration for Children & Families (ACF),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Education, Dept of,Employment & Training Administration,Federal Communications Commission (FCC),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) 10000   0 0 2022-07-09T05:21:38-04:00
2815878 POWERS PYLES SUTTER & VERVILLE, P.C. 897e7987-96e8-4860-941c-013e873ac800 Q2 POWERS PYLES SUTTER & VERVILLE, P.C. 32008 CORNERSTONE CARE, INC. 2022 second_quarter MED FY 2022 Consolidated Appropriations Act, H.R. 2471, now P.L. 117-103 American Rescue Plan Act of 2021, H.R. 1319, now P.L. 117-2 Infrastructure Investment and Jobs Act, H.R. 3684, now P.L. 117-58 Build Back Better Act, H.R. 537 CONNECT for Health Act, S. 1512, H.R. 2903 FY 2023 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills Appalachian Regional Commission,Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Economic Development Administration,Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),Treasury, Dept of     0 0 2022-07-09T05:52:41-04:00
2815885 POWERS PYLES SUTTER & VERVILLE, P.C. 34421a6b-5afb-4a78-b951-65bb3a3f5ce6 Q2 POWERS PYLES SUTTER & VERVILLE, P.C. 32008 GATEWAYS HOSPITAL & MENTAL HEALTH CENTER FOUNDATION 2022 second_quarter MED American Rescue Plan Act of 2021, H.R. 1319, now P.L. 117-2 Infrastructure Investment and Jobs Act, H.R. 3684, now P.L. 117-58 Build Back Better Act, H.R. 5376 CONNECT for Health Act, S. 1512, H.R. 2903 FY 2023 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2023 House, Senate Department of Agriculture Appropriations Bills FY 2023 House, Senate Departments of Commerce and Justice, Science and Related Agencies Appropriations Bills FY 2023 House, Senate Financial Services and General Government Appropriations Bills FY 2023 House, Senate Department of Homeland Security Appropriations Bills FY 2023 House, Senate Departments of Transportation, Housing and Urban Development, and Related Agencies Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Comprehensive Addiction and Recovery Legislation House, Senate Legislation to Reform Behavioral Health and Substance Use Disorder Prevention and Treatment House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Legislation to Train More Primary Care and Other Providers House Legislation to Implement Electronic Provider Consultations (E-Consults) with Related Telemedicine in Hospitals House, Senate Infrastructure Bills Administration for Children & Families (ACF),Agency for Healthcare Research & Quality (AHRQ),Agriculture, Dept of (USDA),Bureau of Justice Assistance,Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Justice, Dept of (DOJ),Office of Justice Program,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) 20000   0 0 2022-07-09T08:52:42-04:00
2815891 POWERS PYLES SUTTER & VERVILLE, P.C. d0de20b8-990d-49ec-9824-3e21df8c9cfc Q2 POWERS PYLES SUTTER & VERVILLE, P.C. 32008 PIH HEALTH FOUNDATION 2022 second_quarter MED American Rescue Plan Act of 2021, H.R. 1319, now P.L. 117-2 Infrastructure Investment and Jobs Act, H.R. 3684, now P.L. 117-58 Build Back Better Act, H.R. 5376 CONNECT for Health Act, S. 1512, H.R. 2903 FY 2023 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2023 House, Senate Department of Agriculture Appropriations Bills FY 2023 House, Senate Departments of Commerce and Justice, Science and Related Agencies Appropriations Bills FY 2023 House, Senate Financial Services and General Government Appropriations Bills FY 2023 House, Senate Department of Homeland Security Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Legislation to Train More Primary Care and Other Providers House Legislation to Implement Electronic Provider Consultations (E-Consults) with Related Telemedicine in Hospitals House, Senate Infrastructure Bills Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) 30000   0 0 2022-07-09T09:25:41-04:00
2815902 POWERS PYLES SUTTER & VERVILLE, P.C. b68ea439-dfd7-4f2d-b1ec-9aa95ae89890 Q2 POWERS PYLES SUTTER & VERVILLE, P.C. 32008 HERBERT J. THOMAS MEMORIAL HOSPITAL ASSOCIATION (FKA THOMAS HEALTH) 2022 second_quarter MED Consolidated Appropriations Act, FY 2022, H.R. 2471, now P.L. 117-103 American Rescue Plan Act of 2021, H.R. 1319, now P.L. 117-2 Infrastructure Investment and Jobs Act, H.R. 3684, P.L. 117-58 Build Back Better Act, H.R. 5376 CONNECT for Health Act, S. 1512, H.R. 2903 FY 2022 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2022 House, Senate Department of Agriculture Appropriations Bills FY 2022 House, Senate Departments of Commerce and Justice, Science and Related Agencies Appropriations Bills FY 2022 House, Senate Financial Services and General Government Appropriations Bills FY 2022 House, Senate Department of Homeland Security Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Comprehensive Addiction and Recovery Legislation House, Senate Legislation to Reform Behavioral Health and Substance Use Disorder Prevention and Treatment House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Legislation to Train More Primary Care and Other Providers House Legislation to Implement Electronic Provider Consultations (E-Consults) with Related Telemedicine in Hospitals House, Senate Infrastructure Bills Administration for Children & Families (ACF),Administration on Aging,Agency for Healthcare Research & Quality (AHRQ),Agriculture, Dept of (USDA),Appalachian Regional Commission,Bureau of Labor Statistics (BLS),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Economic Development Administration,Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),Treasury, Dept of 30000   0 0 2022-07-09T10:17:25-04:00
2816064 BEN BARNES GROUP LP 8778baaf-a495-4277-832a-fc42c3c7a676 Q2 BEN BARNES GROUP LP 5415 HUNTSMAN CORPORATION 2022 second_quarter MED CMS Medicare HOUSE OF REPRESENTATIVES,SENATE 18750   0 0 2022-07-10T13:43:05-04:00
2816066 BEN BARNES GROUP LP 5a380b95-6d68-40ec-95d1-b0d6cdfef823 Q2 BEN BARNES GROUP LP 5415 ENVIGO RMS LLC 2022 second_quarter MED Medical/Disease Research HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2022-07-10T13:53:13-04:00
2816137 PENN AVENUE PARTNERS 8b8a5e7f-3f6c-4f6f-b48b-cb5aafeefdb1 Q2 PENN AVENUE PARTNERS 400918672 CLIFFSIDE LABS, LLC 2022 second_quarter MED Policy and regulatory matters related to the clinical laboratory industry.   20000   0 0 2022-07-10T20:40:02-04:00
2816333 BRAMER GROUP LLC bf095adc-9d1d-4c21-a07e-e7a45cc571c1 Q2 BRAMER GROUP LLC 401103355 TACTICAL MEDICAL SOLUTIONS, LLC 2022 second_quarter MED Medical Training, FY 2022 NDAA Army, Dept of (Other),Defense, Dept of (DOD) 8250   0 0 2022-07-11T11:17:19-04:00
2816516 PROTON THERAPY CONSORTIUM FKA NATIONAL ASSOCIATION FOR PROTON THERAPY 9946bb78-32af-4862-a17a-3bc444dcc4e3 Q2 PROTON THERAPY CONSORTIUM FKA NATIONAL ASSOCIATION FOR PROTON THERAPY 401106232 PROTON THERAPY CONSORTIUM FKA NATIONAL ASSOCIATION FOR PROTON THERAPY 2022 second_quarter MED Commercial insurance coverage for radiation oncology; Physician fee schedule; HOPPS 2022; RO APM Model; Medicare & Medicaid coverage for radiation oncology; proton therapy Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE     0 0 2022-07-11T14:42:53-04:00
2816735 THE HARRIS FIRM 29ab18dd-e9c2-4f47-be95-fc753ae5e0e7 Q2 THE HARRIS FIRM 68376 HOLISTIC INDUSTRIES INC. 2022 second_quarter MED Issues pertaining to cannabis CSA scheduling. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2022-07-11T21:30:21-04:00
2816742 NATURAL RESOURCE RESULTS LLC 6babfa1a-617e-4205-8b13-37bed38f656d 2A NATURAL RESOURCE RESULTS LLC 321555 SHINE MEDICAL TECHNOLOGIES 2022 second_quarter MED Support funding at DOE for fusion technology development. Energy, Dept of,SENATE 30000   0 0 2022-07-11T22:15:35-04:00
2816872 EFB ADVOCACY, LLC 902e9a96-bc91-4dfd-a49b-e976fc5fd111 Q2 EFB ADVOCACY, LLC 401104430 UNITED FOR MEDICAL RESEARCH 2022 second_quarter MED Funding Issues Related to the National Institutes of Health HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2022-07-12T09:55:45-04:00
2817070 THE ROOSEVELT GROUP 7630260e-0ed1-4144-9cb9-004932c58f97 Q2 THE ROOSEVELT GROUP 400886595 LSU HEALTH SCIENCES FOUNDATION 2022 second_quarter MED Provide advocacy and support of research and development efforts inside the DoD and NIH HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2022-07-12T12:14:39-04:00
2817093 THE ROOSEVELT GROUP a997d765-6756-4370-99ab-e168e426398c Q2 THE ROOSEVELT GROUP 400886595 GUAM REGIONAL MEDICAL CITY 2022 second_quarter MED lobbying on health issues, specifically Medicaid in the US territories HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2022-07-12T12:34:40-04:00
2817223 BLUEBIRD STRATEGIES 334c0e89-e0d1-4737-b96e-da7622a4b7c8 Q2 BLUEBIRD STRATEGIES 401105447 MYOTONIC 2022 second_quarter MED Increasing funding for Myotonic Dystrophy research. Fiscal Year 2023 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE     0 0 2022-07-12T13:57:55-04:00
2817227 BLUEBIRD STRATEGIES b27f060d-e96b-4d40-8fad-aa428ca6c523 Q2 BLUEBIRD STRATEGIES 401105447 MYRIAD GENETICS, INC. 2022 second_quarter MED Legislation to regulate clinical labs under CLIA and FDA. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2022-07-12T13:59:13-04:00
2817285 BOSE PUBLIC AFFAIRS GROUP a04e3a5c-9bd0-414a-9977-02664cb51228 Q2 BOSE PUBLIC AFFAIRS GROUP 297294 AMERICAN ACADEMY OF ANESTHESIOLOGIST ASSISTANTS 2022 second_quarter MED issues related to licensure Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) 10000   0 0 2022-07-12T14:30:18-04:00
2817332 THE CONSILIO GROUP 0a5e2709-1e2d-4e0a-80d0-6f53479e5d44 Q2 THE CONSILIO GROUP 400374717 DETECTACHEM 2022 second_quarter MED Chemical detection test for COVID-19 Air Force, Dept of,Defense, Dept of (DOD),Education, Dept of,Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Navy, Dept of,SENATE,White House Office 16500   0 0 2022-07-12T14:57:34-04:00
2817835 BROYDRICK & ASSOCIATES 133b4539-4bad-412e-8d31-eeb0bd48a90d Q2 BROYDRICK & ASSOCIATES 7268 NORTHSTAR RADIOISOTOPES, LLC 2022 second_quarter MED DOE policies and cooperative agreements expansion legislation, Nuclear medicine CMS Reimbursement, NNSA reorganization. Funding for new cooperative agreements HOUSE OF REPRESENTATIVES,SENATE     0 0 2022-07-13T10:10:28-04:00
2818051 CRISPR THERAPEUTICS, INC. 57caf115-24b0-4801-bddf-169806559ff9 Q2 CRISPR THERAPEUTICS, INC. 401105184 CRISPR THERAPEUTICS, INC. 2022 second_quarter MED General issues related to FDA approval policies for cell and gene therapies. Policies related to the reauthorization of the Prescription Drug User Fee Act. HOUSE OF REPRESENTATIVES,SENATE   90000 0 0 2022-07-13T12:23:56-04:00
2818082 THE DLM GROUP e9d72a3a-892e-4d6c-b88c-30dd4986e14e Q2 THE DLM GROUP 313794 GENESIS HEALTH CARE, INC. 2022 second_quarter MED request congressionally directed spending.   7500   0 0 2022-07-13T12:53:32-04:00
2818237 MAGILL ASSOCIATES, LLC b955cf93-002d-4ea5-b22a-725064ae3cb8 Q2 MAGILL ASSOCIATES, LLC 401103511 THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES 2022 second_quarter MED H.R. 2471 - Consolidated Appropriations Act, 2022 FY 2022 appropriations for the development of a synthetic vaccine Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2022-07-13T14:31:14-04:00
2818346 SQUIRE PATTON BOGGS 65e9a180-e35f-42f2-835d-84c351e136fc Q2 SQUIRE PATTON BOGGS 30906 LA MAESTRA FOUNDATION ON BEHALF OF LA MAESTRA FAMILY CLINIC, INC. 2022 second_quarter MED Funding support for federally qualified health centers; reauthorization of programs HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2022-07-13T15:37:44-04:00
2818582 MICHAEL N. MCCARTY LAW OFFICE PLLC f97ce2d2-c852-40e9-a2c5-7ca7ee9c96a5 Q2 MICHAEL N. MCCARTY LAW OFFICE PLLC 401104300 AMERICAN MEDICAL TECHNOLOGISTS 2022 second_quarter MED Support funding for the Centers for Disease Control & Prevention (CDC) Advanced Molecular Detection (AMD) program; support funding for CDC's Environmental Health Laboratory to (1) generate pediatric reference intervals for clinical diagnostic testing on children and (2) harmonize clinical laboratory test results across different testing platforms; legislation establishing a regulatory framework for laboratory-developed tests (LDTs), including S. 1666, S. 2209, and H.R. 4128. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2022-07-13T18:56:51-04:00
2818587 WATKINS & EAGER PLLC c740b98e-51f9-4e91-8bd3-ca9f399e2c1d Q2 WATKINS & EAGER PLLC 401104403 NATIONAL FRAGILE X FOUNDATION 2022 second_quarter MED Encourage Members to act favorably on legislation that would benefit those impacted by Fragile X & their constituents; possible trail to help individuals with Fragile X. HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2022-07-13T20:09:39-04:00
2818690 SAM ACTION, INC. ecf1699f-cac4-4313-a7ec-e7dfbec1902f Q2 SAM ACTION, INC. 401104337 SAM ACTION, INC. 2022 second_quarter MED H.R. 3797, Medical Marijuana Research Act, S. 2032, Cannabidiol and Marijuana Research Expansion Act, to lower the barriers of researching marijuana. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Natl Drug Control Policy (NDCP),SENATE   10000 0 0 2022-07-14T09:38:25-04:00
2818842 RELX INC. 38f9d66d-b039-4b5b-80b6-8d12a44b97d0 Q2 RELX INC. 49511 RELX INC 2022 second_quarter MED Issues related to US-UK Cancer Summit and Cancer Moonshot initiative. Health & Human Services, Dept of (HHS),Office of Science & Technology Policy (OSTP)   630000 0 0 2022-07-14T11:49:59-04:00
2818905 MICHIGAN TECHNOLOGICAL UNIVERSITY b99791aa-f505-494d-a5b7-006633c5613b Q2 MICHIGAN TECHNOLOGICAL UNIVERSITY 25181 MICHIGAN TECHNOLOGICAL UNIVERSITY 2022 second_quarter MED Discussed issues of interest related to higher education for the COVID-19 pandemic. HOUSE OF REPRESENTATIVES,SENATE   50000 0 0 2022-07-14T12:16:53-04:00
2818909 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) ab4bb536-3e0d-4747-9228-37371421952f Q2 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 1466 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 2022 second_quarter MED AACC joined with other healthcare groups in providing input to the Senate HELP Committee on the provisions in the Food and Drug Administration Safety and Landmark Advances Act pertaining to the Verifying Accurate Leading-edge IVCT Development Act. AACC met with House and Senate staff and conducted a grassroots campaign urging Congress to keep the VALID Act out of the FDASLA legislation. HOUSE OF REPRESENTATIVES,SENATE   120000 0 0 2022-07-14T12:24:08-04:00
2819110 OLD NORTH STRATEGIES, LLC 8aff8cef-cf6f-4a9d-86ba-291a2ab7d556 Q2 OLD NORTH STRATEGIES, LLC 401106174 EXELA PHARMA SCIENCES, LLC 2022 second_quarter MED bio pharma supply chain reform HOUSE OF REPRESENTATIVES,SENATE 78000   0 0 2022-07-14T14:10:25-04:00
2819188 MANATOS & MANATOS 0fea98bf-04c0-42bd-9756-9c9d60ddac8c Q2 MANATOS & MANATOS 23634 BARBARA ANN KARMANOS CANCER INSTITUTE 2022 second_quarter MED General issues HOUSE OF REPRESENTATIVES,SENATE     0 0 2022-07-14T14:30:26-04:00
2819248 PARDES BIOSCIENCES, INC. f0f621c3-7532-4264-a92d-e5f40ff50dcd Q2 PARDES BIOSCIENCES, INC. 401106493 PARDES BIOSCIENCES, INC. 2022 second_quarter MED COVID Oral Antivirals Natl Institutes of Health (NIH)   120000 0 0 2022-07-14T14:54:50-04:00
2819794 MARSHALL & POPP, LLC 9af5225f-3314-47dc-8f4b-6e5edb9d6c74 Q2 MARSHALL & POPP, LLC 401105121 BUTTERFLY NETWORK, INC. 2022 second_quarter MED Issues related to medical device manufacturing / insurance / technology, including S.3799, the PREVENT Pandemics Act. Issues related to FDA regulation of medical devices, including S.4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2022-07-15T00:38:34-04:00
2819804 IMPACT HEALTH POLICY PARTNERS d148405c-41ac-4158-8ef6-a0bb0bb4fe93 Q2 IMPACT HEALTH POLICY PARTNERS 401104696 ABBOTT LABORATORIES 2022 second_quarter MED Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2022-07-15T07:23:37-04:00
2819807 IMPACT HEALTH POLICY PARTNERS cb0d2621-9653-42ef-9f3a-46cb4382e7d4 Q2 IMPACT HEALTH POLICY PARTNERS 401104696 CHILDREN'S HOSPITAL COLORADO 2022 second_quarter MED Issues related to pediatric research and children's hospital graduate medical education. H.R.6000, Cures 2.0 Act. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2022-07-15T07:25:27-04:00
2819814 IMPACT HEALTH POLICY PARTNERS fb279c2f-3ae8-437f-9cd8-ca9dad196911 Q2 IMPACT HEALTH POLICY PARTNERS 401104696 HACKENSACK MERIDIAN HEALTH 2022 second_quarter MED Issues related to research funding, including ARPA-H, NIH, organ transplants, and other matters. H.R.6000, Cures 2.0 Act. HOUSE OF REPRESENTATIVES,SENATE,White House Office 40000   0 0 2022-07-15T07:30:02-04:00
2820258 BLUESTONE STRATEGIES, LLC 574af257-7ac0-4b87-98a2-a6b9e09a775a Q2 BLUESTONE STRATEGIES, LLC 400658980 VALYRIAN SMOKE LLC 2022 second_quarter MED Medical Research and Funding for Traumatic Brain Injury and Post-Traumatic Stress Disorder HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2022-07-15T11:29:47-04:00
2820331 THE CJR GROUP, INC. a2949c52-ef74-44d8-a5f6-483e185e0866 Q2 THE CJR GROUP, INC. 288293 UNIVERSITY HOSPITALS HEALTH SYSTEM 2022 second_quarter MED Issues related to funding for hospitals HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2022-07-15T11:47:47-04:00
2820487 GOVERNMENT COUNSEL, LLC ca65d829-202a-4008-8d87-51e245b35075 Q2 GOVERNMENT COUNSEL, LLC 401105070 HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) 2022 second_quarter MED S.2209/H.R.4128-Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021; S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, and H.R. 7667, Food and Drug Amendments of 2022, relating to the establishment of a regulatory framework for laboratory developed tests. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2022-07-15T12:54:30-04:00
2820776 TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 6aa7fa40-f1e6-48b4-9cf2-d890bc07c91f Q2 TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 38608 TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 2022 second_quarter MED Supporting COVID-19 Legislation Telehealth / TREAT Act S4421, CONNECT Act, S2741 Graduate Medical Education Community Health Worker Legislation NIH Funding ARPA-H HOUSE OF REPRESENTATIVES,SENATE   40000 0 0 2022-07-15T15:06:30-04:00
2820991 SQUIRE PATTON BOGGS 97be3928-43dc-4821-841c-4232e137d142 Q2 SQUIRE PATTON BOGGS 30906 ALLIANCE FOR BIOSECURITY 2022 second_quarter MED Preparedness and response as it relates to Biosecurity. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 100000   0 0 2022-07-15T16:14:04-04:00
2821152 SQUIRE PATTON BOGGS 63570522-bfb1-4695-9614-4ada9e8cadbf Q2 SQUIRE PATTON BOGGS 30906 IMPACT JOURNALS, LLC 2022 second_quarter MED National Library of Medicine indexing matters. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2022-07-15T17:05:18-04:00
2821224 FORBES-TATE 84221e77-8cdb-4a23-9358-ed1accd4a9af Q2 FORBES-TATE 400976792 AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION 2022 second_quarter MED Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2022-07-15T17:44:07-04:00
2821343 FORBES-TATE 20494d44-81e3-46ba-9587-b195715889ac Q2 FORBES-TATE 400976792 AMGEN USA, INC. 2022 second_quarter MED Issues related to Biosimilars; Issues related to drug pricing. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2022-07-15T18:24:27-04:00
2821493 CORNERSTONE GOVERNMENT AFFAIRS, INC. 91551bc7-5395-4fa5-a66e-dc76b4055777 Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 ADVANCED MATERIALS AND DEVICES, INC. 2022 second_quarter MED Educated key government stakeholders on AMADs products applicable to the military as part of the National Defense Authorization Act and appropriations committees bills. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2022-07-15T22:48:00-04:00
2821551 REPUBLIC CONSULTING, LLC 193466ad-99bc-4677-b6eb-e7b47058f3db Q2 REPUBLIC CONSULTING, LLC 401016871 IQVIA 2022 second_quarter MED Monitored health Data Policy. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2022-07-16T09:05:36-04:00
2821617 STANFORD UNIVERSITY d4bcef6c-7bad-4b34-8836-56e4e2aa5f08 Q2 STANFORD UNIVERSITY 36492 STANFORD UNIVERSITY 2022 second_quarter MED H.R.708; S.168 Temporary Reciprocity to Ensure Access to Treatment Act H.R. 2256, S. 834 Resident Physician Shortage Reduction Act of 2021 HOUSE OF REPRESENTATIVES,SENATE   100000 0 0 2022-07-16T10:46:31-04:00
2821624 FORBES-TATE 396f1e9f-c53f-4881-a279-eb894395f2de Q2 FORBES-TATE 400976792 CALIFORNIA LIFE SCIENCES ASSOCIATION 2022 second_quarter MED Issues related to the life sciences industry; Issues related to drug pricing and international reference pricing. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2022-07-16T11:06:38-04:00
2821699 FORBES-TATE 874c1016-5f95-445f-a49d-da96a7197835 Q2 FORBES-TATE 400976792 COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION 2022 second_quarter MED Issues pertaining to government-wide federal regulation of cannabis. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2022-07-16T11:51:17-04:00
2821714 FORBES-TATE 0244b46a-fb76-4978-afe5-2401b2acd06a Q2 FORBES-TATE 400976792 CSL BEHRING 2022 second_quarter MED Issues related to COVID-19 response efforts. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2022-07-16T12:13:52-04:00
2821886 HAWLEY LLC 4a92ad6e-320c-4e80-9b01-27fdd5ff2e54 Q2 HAWLEY LLC 401105460 MLA ASSOCIATES ON BEHALF OF CLARK STREET ASSOCIATES LLC ON BEHALF OF QORVO 2022 second_quarter MED Issues related to pathogen testing for COVID 19 and other diseases, including the National Defense Authorization Act for FY2023 Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2022-07-16T14:58:58-04:00
2822220 CORNERSTONE GOVERNMENT AFFAIRS, INC. 5cb3d169-36ed-43ca-909d-d7fb78489d7b Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 AMERICAN SOCIETY FOR RADIATION ONCOLOGY 2022 second_quarter MED To discuss access to radiation oncology. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES 50000   0 0 2022-07-16T23:33:09-04:00
2822410 MCHUGH LEMAY ASSOC., LLC a9358f88-3270-4a75-9f82-53111ba01d17 Q2 MCHUGH LEMAY ASSOC., LLC 401105253 CLARK STREET ASSOCIATES LLC ON BEHALF OF QORVO 2022 second_quarter MED Issues related to COVID testing - including H.R. 7900 - National Defense Authorization Act of 2023. Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2022-07-17T11:38:47-04:00
2822632 CAPITOL COUNSEL LLC 4da87665-aff3-4fda-8e5c-c4648c69453a Q2 CAPITOL COUNSEL LLC 313715 BLUE EARTH DIAGNOSTICS, INC. 2022 second_quarter MED To gain support for adequate Medicare reimbursement for diagnostic radiopharmaceuticals; Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2022-07-17T16:13:31-04:00
2822644 CAPITOL COUNSEL LLC 25e0bdcf-0ec2-43b6-80db-906bb50a7018 Q2 CAPITOL COUNSEL LLC 313715 EMD SERONO, INC. 2022 second_quarter MED Monitoring and engaging on health policy proposals coming before the House of Representatives and the Administration pertaining to the availability and pricing of prescription drugs. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2022-07-17T16:26:28-04:00
2822963 CORNERSTONE GOVERNMENT AFFAIRS, INC. 31b95f88-9259-47dd-b366-be75e534816d Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 CHILDREN'S NATIONAL MEDICAL CENTER 2022 second_quarter MED Representation on health-related issues including reimbursement, research, public-health & clinical care Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 50000   0 0 2022-07-17T22:39:24-04:00
2822973 CORNERSTONE GOVERNMENT AFFAIRS, INC. 809e24e5-40a9-43a3-b918-dbd630d5585f Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 CITY OF HOPE MEDICAL CENTER 2022 second_quarter MED Medicare/Medicaid reimbursement, clinical research HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2022-07-17T23:01:41-04:00
2823193 THE JACKSON LABORATORY d3ae5a4e-63bc-4718-9aa3-fedb0d1afa02 Q2 THE JACKSON LABORATORY 401104723 THE JACKSON LABORATORY 2022 second_quarter MED Issues related to biomedical research, and animals used in biomedical research. Issues related to the creation of a proposed Advanced Research Project Agency-Health agency. HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2022-07-18T09:39:33-04:00
2823209 EMERGENT STRATEGIES 2dbd5ca7-858f-404f-ab24-33a839ddb6aa Q2 EMERGENT STRATEGIES 401104778 ADVAMED:ADVANCED MEDICAL TECHNOLOGY ASSOCIATION 2022 second_quarter MED Health tax issues and trade, H.R.4043 - Ensuring Patient Access to Critical Breakthrough Products Act of 2021 Issues related to Small Business Innovation Research Program Medical Device User Fee Amendments IV HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2022-07-18T09:48:06-04:00
2823324 DQB INTERNATIONAL 35aa37f0-db76-4f17-a30d-dce5fe49759d Q2 DQB INTERNATIONAL 291834 TEXAS BIOMEDICAL RESEARCH INSTITUTE 2022 second_quarter MED FY 2023 Labor, HHS Appropriations Bill HOUSE OF REPRESENTATIVES,SENATE     0 0 2022-07-18T10:20:32-04:00
2823429 TIBER CREEK GROUP 55a85905-f155-4462-b8de-c5cb8553d4e5 Q2 TIBER CREEK GROUP 20744 JAZZ PHARMACEUTICALS 2022 second_quarter MED Issues related to the FDA and S. 3032 - the FDA STATES Act (115th Congress), and Health and Human Services pertaining to CBD policies. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2022-07-18T10:55:53-04:00
2823601 BURRELL INTERNATIONAL GROUP LLC 5cc8a662-6e58-4719-b9a5-6aa1639bf175 Q2 BURRELL INTERNATIONAL GROUP LLC 401103483 AVALO THERAPEUTICS 2022 second_quarter MED Medical Countermeasures Development of Therapeutics for COVID-19 and Rare Disease HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2022-07-18T11:37:24-04:00
2823655 CALIFORNIA LIFE SCIENCES a7095cba-95d2-44b2-b76c-cd0d56d1b964 Q2 CALIFORNIA LIFE SCIENCES 7758 CALIFORNIA LIFE SCIENCES 2022 second_quarter MED Support NIH research funding. Support implementation of 21st Century Cures Act. Support implementation of MCIT rule. HOUSE OF REPRESENTATIVES,SENATE   190000 0 0 2022-07-18T11:49:35-04:00
2823771 AMERICAN ASSOCIATION FOR CANCER RESEARCH 808e8bdd-eeb1-42da-813a-571c80e4aa8b Q2 AMERICAN ASSOCIATION FOR CANCER RESEARCH 400601833 AMERICAN ASSOCIATION FOR CANCER RESEARCH 2022 second_quarter MED Cancer research Oncology product review at the FDA Pediatric research and cancer care Clinical trials Diversity in clinical trials HOUSE OF REPRESENTATIVES,SENATE   100000 0 0 2022-07-18T12:15:19-04:00
2823854 UNIVERSITY OF MARYLAND, BALTIMORE (UMB) c88cd747-13a2-425a-afc0-a2391c9983e2 Q2 UNIVERSITY OF MARYLAND, BALTIMORE (UMB) 401103161 UNIVERSITY OF MARYLAND, BALTIMORE (UMB) 2022 second_quarter MED NONE     10000 0 0 2022-07-18T12:27:46-04:00
2824099 DREXEL UNIVERSITY 826aa1b1-2907-4e68-a2a5-d39329a0196d Q2 DREXEL UNIVERSITY 40032273 DREXEL UNIVERSITY 2022 second_quarter MED Research, education and other matters related to higher ed. HOUSE OF REPRESENTATIVES,SENATE   81000 0 0 2022-07-18T12:59:01-04:00
2824101 TWENTY-FIRST CENTURY GROUP, INC. 1dc81afa-c877-46aa-bd37-07482c0172ad Q2 TWENTY-FIRST CENTURY GROUP, INC. 38687 NRX PHARMACEUTICALS INC (FORMERLY KNOWN AS NEURORX) 2022 second_quarter MED Research and treatment related to suicide prevention for veterans and patients with bipolar depression. HOUSE OF REPRESENTATIVES,SENATE 24000   0 0 2022-07-18T12:59:07-04:00
2824111 DREXEL UNIVERSITY 0936e4a1-0030-4fa9-a761-1e6db80df79f Q2 DREXEL UNIVERSITY 40032273 ST. CHRISTOPHER'S HOSPITAL FOR CHILDREN 2022 second_quarter MED Children's health and welfare HOUSE OF REPRESENTATIVES,SENATE     0 0 2022-07-18T13:00:31-04:00
2824117 AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS 9bf85c20-037d-4943-8dde-39cf597397a5 Q2 AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS 52105 AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS 2022 second_quarter MED Support appropriations for the Peer-Reviewed Orthopaedic Research Program (PRORP). PRORP is a competitive grant program that funds research pertaining to extremity war injuries. Support Research through support of HR 869/S289 Research Investment to Spark the Economy (RISE) Act Support legislation aimed at accelerating medical research and patient access to novel therapeutics HR 6000 the "Cures 2.0 Act" HOUSE OF REPRESENTATIVES,SENATE   374911 0 0 2022-07-18T13:01:41-04:00
2824163 STRATEGIES 360 1979df22-1a58-42c4-9f86-5a424bfb1565 Q2 STRATEGIES 360 79175 INNOVA MEDICAL GROUP, INC. 2022 second_quarter MED Issues relating to the FDA approval process for medical testing HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2022-07-18T13:10:02-04:00
2824405 TWENTY-FIRST CENTURY GROUP, INC. 7e8cd6a6-2302-4f04-aba7-54195c4437a8 Q2 TWENTY-FIRST CENTURY GROUP, INC. 38687 GLOBAL ALZHEIMER'S PLATFORM INNOVATIONS PBC 2022 second_quarter MED Issues related to diversity in clinical trials, Alzheimers research, and HR 5585, the ARPA-H Act. HOUSE OF REPRESENTATIVES,SENATE 24000   0 0 2022-07-18T13:52:24-04:00
2824575 ALLIANCE FOR AGING RESEARCH 1eaef260-06c1-4586-82f3-56b28c98bc77 Q2 ALLIANCE FOR AGING RESEARCH 401010854 ALLIANCE FOR AGING RESEARCH 2022 second_quarter MED -Establishing a Neuroscience Center of Excellence within the FDA -H.R. 6000 Cures 2.0 Act -FDA clinical trial diversity -Patient-centered outcomes research principles with ARHQ Agency for Healthcare Research & Quality (AHRQ),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE     0 0 2022-07-18T14:16:45-04:00
2824605 RICCHETTI INCORPORATED f6b8c8c9-0a3a-4e8a-b63c-5117e29f0b42 Q2 RICCHETTI INCORPORATED 62778 VAXART INC. 2022 second_quarter MED Legislative and regulatory policies regarding oral vaccine development and funding HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2022-07-18T14:19:58-04:00
2824633 DANA-FARBER CANCER INSTITUTE b4bf3c99-3a71-4b61-bb67-d1165b3c9509 Q2 DANA-FARBER CANCER INSTITUTE 401106163 DANA-FARBER CANCER INSTITUTE 2022 second_quarter MED Support policies to remove barriers to clinical trials, promote research generally, address issues in childhood cancer research including HR5030 / S2706 - The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act; HR623 / S1521 - Gabriella Miller Kids First Research Act 2.0; HR3089 / S1544 Accelerating Kids Access to Care Act; HR 6000, CURES 2.0 Act; H.R. 5585, the Advanced Research Project Agency-Health (ARPA-H) Act HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE   78000 0 0 2022-07-18T14:24:02-04:00
2824734 BARKER LEAVITT, PLLC (SKA MR. JAMES C. BARKER) 9bdb7201-0789-4f21-9b7d-e1e3fe3d6cf7 Q2 BARKER LEAVITT, PLLC (SKA MR. JAMES C. BARKER) 292538 SONIC HEALTHCARE USA 2022 second_quarter MED Issues relating to the regulation of laboratory developed tests, the VALID Act, issues relating to PAMA (the SALSA Bill), federal policies relating to the implementation of the anti-kickback requirements of the Support for Patients and Communities Act. Physician Lab Fee schedule. Anatomic Fee Schedule and Surprise Billing. COVID Testing and billing procedures. COVID Vaccine Federal Mandate. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2022-07-18T14:38:56-04:00
2825366 THE LIVINGSTON GROUP, LLC cbe60385-c839-4c6c-bf9c-53e4d7869fdf Q2 THE LIVINGSTON GROUP, LLC 49635 INNOVATIVE VACCINE TECHNOLOGIES 2022 second_quarter MED H.R. 2471 - Consolidated Appropriations Act, 2022 FY 2022 appropriations for the development of a synthetic vaccine Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2022-07-18T15:51:27-04:00
2825404 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 732f83d9-d125-4de2-a4c4-0baa4d0526b3 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 DEFENSE HEALTH RESEARCH CONSORTIUM 2022 second_quarter MED HR 8236, FY23 Defense Appropriations Act HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2022-07-18T15:54:27-04:00
2825423 BIOTECHNOLOGY INNOVATION ORGANIZATION 648ce811-86d9-4a96-9234-f4295d0b7cdc Q2 BIOTECHNOLOGY INNOVATION ORGANIZATION 6245 BIOTECHNOLOGY INNOVATION ORGANIZATION 2022 second_quarter MED Biodefense Research, Development and Procurement Issues (Non-Funding) ---Executive Order on Modernizing Influenza Vaccines ---Implementation of 21st Century Cures Act of 2016 ---Implementation of Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Implementation of Pandemic and All-Hazards Preparedness and Advancing Innovation (PAHPAI) Act of 2019 ---Reauthorization of PAHPA ---Tropical Disease Priority Review (PRV) Program ---White House National Biodefense Strategy Coronavirus (COVID-19) Pandemic ---H.R.550: Immunization Information Systems ---Implementation of Consolidated Appropriations Act for FY 2021 ---R&D Funding for Medical Countermeasures ---Senate HELP Pandemic Preparedness White Paper Funding for Antimicrobial Resistance (AMR) Programs ---FY 2023 Appropriations ---H.R.3932/S.2076: Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) ---H.R.4127: DISARM Act ---Implementation of Consolidated Appropriations Act for FY 2021 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---FY 2023 Appropriations ---H.R.4521: America COMPETES Act of 2022 ---H.R.5376: Build Back Better Act of 2021 ---S.1260: United States Innovation and Competition Act of 2021 ---Build Back Better Act (Discussion Draft Senate) ---Funding for Strategic National Stockpile ---Health Defense Operations Funding Designation ---Implementation of Consolidated Appropriations Act for FY 2021 ---Implementation of Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Reauthorization of PAHPA Funding for National Institutes of Health ---FY 2023 Appropriations ---H.R.623: Gabriella Miller Kids First Research Act 2.0 ---H.R.5585: Advanced Research Projects Agency for Health (ARPA-H) Act Funding for the Centers for Disease Control and Prevention Vaccine Programs ---FY 2023 Appropriations ---Funding for 2022-2023 Influenza Season Preparedness and R… Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Security Council (NSC),Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE,White House Office   3120000 0 0 2022-07-18T15:55:27-04:00
2825552 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 9134d966-2c37-40f4-b35a-27e7e30a3a60 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 PANCREATIC CANCER ACTION NETWORK (PANCAN) 2022 second_quarter MED cancer research at DoD and NIH HR 8236, FY23 Defense Appropriations Act Peer-Reviewed Pancreatic Cancer Research Program HR 8295, FY23 Labor-HHS-Education Act, NIH research on pancreatic cancer HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2022-07-18T16:10:10-04:00
2825574 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. e6814fbb-a4e2-415a-b470-717724987ab0 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 FOUNDATION FOR PERIPHERAL NEUROPATHY 2022 second_quarter MED HR 8236 FY23 Defense Appropriations Act, DoD funding for peripheral neuropathy research HR 8295,FY23 Labor-HHS-Education Act, NIH Funding for peripheral neuropathy research HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2022-07-18T16:13:52-04:00
2825584 MARSHFIELD CLINIC HEALTH SYSTEM 0c70e158-3970-496e-a26b-7d41fcdfd371 Q2 MARSHFIELD CLINIC HEALTH SYSTEM 57830 MARSHFIELD CLINIC HEALTH SYSTEM 2022 second_quarter MED COVID-19, agricultural occupational health, NIOSH HOUSE OF REPRESENTATIVES,SENATE   60000 0 0 2022-07-18T16:15:47-04:00
2825660 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 61638a43-5370-4fbe-9f79-b9e372054576 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 TUBEROUS SCLEROSIS ALLIANCE 2022 second_quarter MED Tuberous Sclerosis Complex Research Program HR 8295, FY23 Labor-HHS-Appropriations Act, NIH and CDC research on tuberous sclerosis complex HR 8236, FY23 Defense Appropriations Act HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2022-07-18T16:34:47-04:00
2825747 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. ec1c5579-7649-4a03-86c8-77bb615a562e Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 ECRI 2022 second_quarter MED Federal Grant and contracting opportunities related to maternal mortality, patient safety and vaccines. Centers For Medicare and Medicaid Services (CMS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2022-07-18T16:44:19-04:00
2825898 THE PETRIZZO GROUP, INC. 1bfd88be-b75f-476d-a6a3-d2efe6285f26 Q2 THE PETRIZZO GROUP, INC. 305932 OMEROS CORPORATION 2022 second_quarter MED Advocated for Medicare Part B packaged payment reforms; and the expansion of the non-opioid pain management drug exclusion to the drugs functioning as supplies during a surgical procedure packaging policy. NO PAIN Act HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2022-07-18T17:12:50-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 3233.444ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API